CSPIA
BHVN icon

Cary Street Partners Investment Advisory’s Biohaven BHVN Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-200
Closed -$5.2K – 753
2023
Q3 		$5.2K Sell
200
-150
-43% -$3.12K ﹤0.01% 1462
2023
Q2 		$8.37K Hold
350
– – ﹤0.01% 1290
2023
Q1 		$4.78K Buy
+350
New +$5.57K ﹤0.01% 1335

Other funds holding BHVN

Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cary Street Partners Investment Advisory's BHVN Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Biohaven (BHVN) in Q4 2023, closing a stake of 200 shares — an estimated $5.2K sold.

Cary Street Partners Investment Advisory first reported a position in BHVN in Q1 2023 and held it in 3 quarters. The position peaked at $8.37K in Q2 2023. 218 funds tracked by Wall St. Rank hold BHVN as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Biohaven position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 200 Biohaven shares in Q4 2023, an estimated $5.2K.
  • Cary Street Partners Investment Advisory first reported a position in Biohaven in Q1 2023 and held it in 3 quarters.
  • Cary Street Partners Investment Advisory's Biohaven position peaked at $8.37K in Q2 2023.
  • 218 funds tracked by Wall St. Rank held Biohaven as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.